EUVIMEDEUVIMED entdecken
Crossref

Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation

Fernando Caravaca-Fontán iD, Natalia Polanco, Blanca Villacorta, Anna Buxeda, Armando Coca iD, Ana Ávila, Rocío Martínez-Gallardo, Cristina Galeano, Rosalía Valero, Natalia Ramos, Natalia Allende, Leónidas Cruzado-Vega und 12 weitere

Nephrology Dialysis Transplantation · 2023

DOI: 10.1093/ndt/gfac148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2023. Verfasst von Fernando Caravaca-Fontán und 23 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain. Hauptthemen laut MEDLINE: Glomerulonephritis, Glomerulonephritis, Membranoproliferative, Kidney Failure, Chronic, Kidney Transplantation. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional, Red de Investigación Renal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Membranoproliferative glomerulonephritis (MPGN) represents a histologic pattern of glomerular injury that may be due to several aetiologies. Few studies have comprehensively analysed the recurrence of MPGN according to the current classification system.

Methods

We collected a multicentre, retrospective cohort of 220 kidney graft recipients with biopsy-proven native kidney disease due to MPGN between 1981 and 2021 in 11 hospitals. Demographic, clinical and histologic parameters of prognostic interest were collected. The main outcomes were time to kidney failure, time to recurrence of MPGN and disease remission after recurrence.

Results

The study group included 34 complement-mediated and 186 immune complex–mediated MPGN. A total of 81 patients (37%) reached kidney failure in a median follow-up of 79 months. The main predictors of this event were the development of rejection episodes and disease recurrence. In all, 54 patients (25%) had a disease recurrence in a median of 16 months after kidney transplantation. The incidence of recurrence was higher in patients with dysproteinaemia (67%) and complement-mediated MPGN (62%). In the multivariable model, complement-mediated MPGN emerged as a predictor of recurrence. A total of 33 patients reached kidney failure after recurrence. The main determinants of no remission were early time to recurrence (<15 months), estimated glomerular filtration rate <30 mL/min/1.73 m2 and serum albumin <3.5 g/dL at the time of recurrence.

Conclusions

One-fourth of the patients with native kidney disease due to MPGN developed clinical recurrence in the allograft, especially in cases with complement-mediated disease or in those associated with dysproteinaemia. The kidney outcomes of disease recurrence with currently available therapies are heterogeneous and thus more effective and individualized therapies are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlomerulonephritisGlomerulonephritis, MembranoproliferativeKidney Failure, ChronicKidney TransplantationHumansAntigen-Antibody ComplexComplement System ProteinsRecurrenceRetrospective Studies

Stichwörter der Autor:innen

C3 glomerulopathykidney failuremembranoproliferative glomerulonephritisrecurrenceremission

Substanzen

Antigen-Antibody ComplexComplement System Proteins

Autor:innen und Institutionen

  • Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain.
  • Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
  • Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Department of Nephrology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Department of Nephrology, Hospital del Mar, Institut Mar for Medical Research, Barcelona, Spain.
  • Department of Nephrology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.

ORCID-Profile: Fernando Caravaca-Fontán, Armando Coca, María José Pérez-Sáez

Förderung

  • Instituto de Salud Carlos III
  • Fondo Europeo de Desarrollo Regional
  • Red de Investigación Renal
  • Autonomous Region of Madrid

Zitieren

APA

Caravaca-Fontán, F., Polanco, N., Villacorta, B., Buxeda, A., Coca, A., Ávila, A., Martínez-Gallardo, R., Galeano, C., Valero, R., Ramos, N., Allende, N., Cruzado-Vega, L., Pérez-Sáez, M. J., Sevillano, Á., González, E., Hernández, A., Rodrigo, E., Fernández-Ruiz, M., Aguado, J. M., …, & Spanish Group for the Study of Glomerular Diseases and the Spanish Group of Kidney Transplant (2023). Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfac148

Vancouver

Caravaca-Fontán F, Polanco N, Villacorta B, Buxeda A, Coca A, Ávila A, et al. Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation. Nephrology Dialysis Transplantation. 2023. doi:10.1093/ndt/gfac148

BibTeX
@article{CaravacaFontn2023,
  author = {Caravaca-Fontán, Fernando and Polanco, Natalia and Villacorta, Blanca and Buxeda, Anna and Coca, Armando and Ávila, Ana and Martínez-Gallardo, Rocío and Galeano, Cristina and Valero, Rosalía and Ramos, Natalia and Allende, Natalia and Cruzado-Vega, Leónidas and Pérez-Sáez, María José and Sevillano, Ángel and González, Esther and Hernández, Ana and Rodrigo, Emilio and Fernández-Ruiz, Mario and Aguado, José María and Pérez Valdivia, Miguel Ángel and Pascuall, Julio and Andrés, Amado and Praga, Manuel and Spanish Group for the Study of Glomerular Diseases and the Spanish Group of Kidney Transplant, Spanish Group for the Study of Glomerular Diseases and the Spanish Group of Kidney Transplant},
  title = {Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  doi = {10.1093/ndt/gfac148}
}
Kostenlos starten →